论文部分内容阅读
Type Ⅰ interferons are critical for antiviral immunity and have been widely used in the treatment of HBV and HCV-related hepatitis.However, distinct from HCV, IFN treatments of HBV do not obtain the expected effect.We demonstrated that induced persistent IFNαR signaling is mainly up-regulated on regulatory B cells but not on T cells during IFNα treatment.